Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design.
about
Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies.Synergistic immunotoxin-paclitaxel combination against lymphomaPhase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia.Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia.
P2860
Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Wide Variability in the Time R ...... Implications for Trial Design.
@en
type
label
Wide Variability in the Time R ...... Implications for Trial Design.
@en
prefLabel
Wide Variability in the Time R ...... Implications for Trial Design.
@en
P2093
P2860
P1476
Wide Variability in the Time R ...... Implications for Trial Design.
@en
P2093
Alan S Wayne
Fabian Müller
Ira Pastan
Tyler Cunningham
Xiu Fen Liu
P2860
P304
P356
10.1158/1078-0432.CCR-15-2500
P407
P577
2016-04-25T00:00:00Z